Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aiman Haider

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
European Urology|May 28, 2025
Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort StudyCameron Englman, Busola Adebusoye, Davide Maffei, et al.
European Urology Focus|April 8, 2023
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate LesionsVasilis Stavrinides, Ece Eksi, Ron Finn, et al.
BJU International|March 1, 2023
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imagingJuan Morote, Hayley Pye, Miriam Campistol, et al.
European Journal of Radiology|April 1, 2023
A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centreAlexandre Woernle, Louise Dickinson, Steven Lelie, et al.
BJU International|April 19, 2026
Deep learning for fluorescence confocal microscopy image interpretation in radical prostatectomyLixiang Fang, Nikhil Mayor, Alexander Light, et al.
The Lancet. Oncology|March 27, 2025
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trialEoin Dinneen, Ricardo Almeida-Magana, Tarek Al-Hammouri, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical ProstatectomyEoin Dinneen, Clare Allen, Tom Strange, et al.
The Prostate|February 27, 2019
PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimensSusan Heavey, Helena Costa, Hayley Pye, et al.
European Urology Oncology|November 5, 2024
Management of Small Testicular Masses: A Delphi Consensus StudyKarl H Pang, Giuseppe Fallara, João Lobo, et al.
Trials|July 22, 2022
NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancerEoin Dinneen, Jack Grierson, Ricardo Almeida-Magana, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
European Urology|May 28, 2025
Magnetic Resonance Imaging-led Risk-adapted Active Surveillance for Prostate Cancer: Updated Results from a Large Cohort StudyCameron Englman, Busola Adebusoye, Davide Maffei, et al.
European Urology Focus|April 8, 2023
Magnetic Resonance Imaging Follow-up of Targeted Biopsy-negative Prostate LesionsVasilis Stavrinides, Ece Eksi, Ron Finn, et al.
BJU International|March 1, 2023
Accurate diagnosis of prostate cancer by combining Proclarix with magnetic resonance imagingJuan Morote, Hayley Pye, Miriam Campistol, et al.
European Journal of Radiology|April 1, 2023
A semi-automated software program to assess the impact of second reads in prostate MRI for equivocal lesions: results from a UK tertiary referral centreAlexandre Woernle, Louise Dickinson, Steven Lelie, et al.
BJU International|April 19, 2026
Deep learning for fluorescence confocal microscopy image interpretation in radical prostatectomyLixiang Fang, Nikhil Mayor, Alexander Light, et al.
The Lancet. Oncology|March 27, 2025
Effect of NeuroSAFE-guided RARP versus standard RARP on erectile function and urinary continence in patients with localised prostate cancer (NeuroSAFE PROOF): a multicentre, patient-blinded, randomised, controlled phase 3 trialEoin Dinneen, Ricardo Almeida-Magana, Tarek Al-Hammouri, et al.
Diagnostics (Basel, Switzerland)|May 28, 2022
Negative mpMRI Rules Out Extra-Prostatic Extension in Prostate Cancer before Robot-Assisted Radical ProstatectomyEoin Dinneen, Clare Allen, Tom Strange, et al.
The Prostate|February 27, 2019
PEOPLE: PatiEnt prOstate samPLes for rEsearch, a tissue collection pathway utilizing magnetic resonance imaging data to target tumor and benign tissue in fresh radical prostatectomy specimensSusan Heavey, Helena Costa, Hayley Pye, et al.
European Urology Oncology|November 5, 2024
Management of Small Testicular Masses: A Delphi Consensus StudyKarl H Pang, Giuseppe Fallara, João Lobo, et al.
Trials|July 22, 2022
NeuroSAFE PROOF: study protocol for a single-blinded, IDEAL stage 3, multi-centre, randomised controlled trial of NeuroSAFE robotic-assisted radical prostatectomy versus standard robotic-assisted radical prostatectomy in men with localized prostate cancerEoin Dinneen, Jack Grierson, Ricardo Almeida-Magana, et al.
Pageof 10